144 related articles for article (PubMed ID: 6298424)
41. Antiplatelet effects of KW-7, a new inhibitor of cyclic nucleotide phosphodiesterases.
Wu CC; Wang WY; Kuo RY; Chang FR; Wu YC
Eur J Pharmacol; 2004 Jan; 483(2-3):187-94. PubMed ID: 14729106
[TBL] [Abstract][Full Text] [Related]
42. Resolution of soluble cyclic nucleotide phosphodiesterase isoenzymes, from liver and hepatocytes, identifies a novel IBMX-insensitive form.
Lavan BE; Lakey T; Houslay MD
Biochem Pharmacol; 1989 Nov; 38(22):4123-36. PubMed ID: 2480793
[TBL] [Abstract][Full Text] [Related]
43. Cyclic nucleotide phosphodiesterase in heart and aorta of spontaneously hypertensive rats.
Sharma RV; Bhalla RC
Biochim Biophys Acta; 1978 Oct; 526(2):479-88. PubMed ID: 214127
[No Abstract] [Full Text] [Related]
44. Inhibitory effects of flavonoids on phosphodiesterase isozymes from guinea pig and their structure-activity relationships.
Ko WC; Shih CM; Lai YH; Chen JH; Huang HL
Biochem Pharmacol; 2004 Nov; 68(10):2087-94. PubMed ID: 15476679
[TBL] [Abstract][Full Text] [Related]
45. Phosphodiesterase inhibitors.
Boswell-Smith V; Spina D; Page CP
Br J Pharmacol; 2006 Jan; 147 Suppl 1(Suppl 1):S252-7. PubMed ID: 16402111
[TBL] [Abstract][Full Text] [Related]
46. Differential pharmacologic sensitivity of cyclic nucleotide phosphodiesterase isozymes isolated from cardiac muscle, arterial and airway smooth muscle.
Silver PJ; Hamel LT; Perrone MH; Bentley RG; Bushover CR; Evans DB
Eur J Pharmacol; 1988 May; 150(1-2):85-94. PubMed ID: 2841146
[TBL] [Abstract][Full Text] [Related]
47. Effects of icariin on cGMP-specific PDE5 and cAMP-specific PDE4 activities.
Xin ZC; Kim EK; Lin CS; Liu WJ; Tian L; Yuan YM; Fu J
Asian J Androl; 2003 Mar; 5(1):15-8. PubMed ID: 12646997
[TBL] [Abstract][Full Text] [Related]
48. Inhibition of calmodulin dependent c-AMP-phosphodiesterase by moxaverine and papaverine.
Mannhold R
Arzneimittelforschung; 1988 Dec; 38(12):1806-8. PubMed ID: 2854468
[TBL] [Abstract][Full Text] [Related]
49. Differential effects of cyclic nucleotides and their analogs and various agents on cyclic GMP-specific and cyclic AMP-specific phosphodiesterases purified from guinea pig lung.
Davis CW; Kuo JF
Biochem Pharmacol; 1978 Jan; 27(1):89-95. PubMed ID: 202285
[No Abstract] [Full Text] [Related]
50. Cyclic nucleotide phosphodiesterase inhibition by a benzoic acid derivative.
Killackey JJ; Killackey BA; Philp RB
Agents Actions; 1985 Dec; 17(2):192-6. PubMed ID: 2420162
[TBL] [Abstract][Full Text] [Related]
51. Do conventional plasma cyclic nucleotide phosphodiesterase inhibitors really work in all situations?
Wood PJ; Pao G; Ross G; Smith C
Clin Chim Acta; 1981 Sep; 115(3):405-8. PubMed ID: 6271425
[No Abstract] [Full Text] [Related]
52. Antispasmodic action of 1-diethylaminoethyl-3-(p-methoxybenzyl)-2-quinoxalone (P 201-1) and its inhibitory effect on cyclic 3',5'-nucleotide phosphodiesterase (PDE) activity.
Hayashi S; Ozawa H
Chem Pharm Bull (Tokyo); 1975 Apr; 23(4):810-6. PubMed ID: 171085
[No Abstract] [Full Text] [Related]
53. Irreversible inhibition of calmodulin-sensitive cyclic nucleotide phosphodiesterase.
Sullivan TA; Duemler BH; Kuttesch NJ; Keravis TM; Wells JN
J Cyclic Nucleotide Protein Phosphor Res; 1986; 11(5):355-64. PubMed ID: 2442214
[TBL] [Abstract][Full Text] [Related]
54. Synthesis and phosphodiesterase activity of carboxylic acid mimetics of cyclic guanosine 3',5'-monophosphate.
Tulshian D; Czarniecki M; Doll RJ; Ahn HS
J Med Chem; 1993 Apr; 36(9):1210-20. PubMed ID: 8387599
[TBL] [Abstract][Full Text] [Related]
55. Inhibition of cyclic nucleotide phosphodiesterases by methylxanthines and related compounds.
Francis SH; Sekhar KR; Ke H; Corbin JD
Handb Exp Pharmacol; 2011; (200):93-133. PubMed ID: 20859794
[TBL] [Abstract][Full Text] [Related]
56. Effect of papaverine analogues on 3', 5'-adenosine monophosphate phosphodiesterase activity in rat brain.
Stancheva S; Uzunov P; Stoytchev T
Acta Physiol Pharmacol Bulg; 1980; 6(1):41-7. PubMed ID: 6250318
[TBL] [Abstract][Full Text] [Related]
57. The effect of cyclic AMP and cyclic GMP phosphodiesterase inhibitors on the superoxide burst of guinea-pig peritoneal macrophages.
Turner NC; Wood LJ; Burns FM; Gueremy T; Souness JE
Br J Pharmacol; 1993 Apr; 108(4):876-83. PubMed ID: 8387385
[TBL] [Abstract][Full Text] [Related]
58. A new generation of phosphodiesterase inhibitors: multiple molecular forms of phosphodiesterase and the potential for drug selectivity.
Weishaar RE; Cain MH; Bristol JA
J Med Chem; 1985 May; 28(5):537-45. PubMed ID: 2985781
[TBL] [Abstract][Full Text] [Related]
59. Selective inhibitor of platelet cyclic adenosine monophosphate phosphodiesterase, cilostamide, inhibits platelet aggregation.
Hidaka H; Hayashi H; Kohri H; Kimura Y; Hosokawa T; Igawa T; Saitoh Y
J Pharmacol Exp Ther; 1979 Oct; 211(1):26-30. PubMed ID: 226672
[No Abstract] [Full Text] [Related]
60. Myofibrillar bound cyclic nucleotide phosphodiesterase in heart and skeletal muscle.
Worby A; Mensah LM; Murray KJ
Biochem Soc Trans; 1992 May; 20(2):129S. PubMed ID: 1327896
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
